Health care stocks were mixed premarket Tuesday with the Health Care Select Sector SPDR Fund (XLV) down 1.2% and the iShares Biotechnology ETF (IBB) recently up 0.3%.
UnitedHealth Group (UNH) shares declined by over 9% after the company suspended its 2025 outlook and named Stephen Hemsley as chief executive, effective immediately, succeeding Andrew Witty.
CNS Pharmaceuticals (CNSP) shares surged by over 92% after the company said it has acquired from Cortice Biosciences orphan drug designation for late-stage abeotaxane TPI 287 as a potential treatment for glioblastoma multiforme.
Legend Biotech (LEGN) shares were up over 1% after the company reported a narrower Q1 adjusted net loss as revenue more than doubled during the period.